Not finding it? Sign in to also search OpenAlex live.
-
Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain2023 The Journal of Headache and Pain article Medicine Cannabis and Cannabinoid Research Open access
Adriana Della Pietra, Georgii Krivoshein, Konstantin Ivanov, Raisa Giniatullina, Henna-Kaisa Jyrkkänen, Ville Leinonen, +4 more
27citations -
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study2021 Journal of Neurology Neurosurgery & Psychiatry article Medicine Migraine and Headache Studies Open access
Michel Dominique Ferrari, Uwe Reuter, Peter James Goadsby, Gabriel Paiva da Silva Lima, Subhayan Mondal, Shihua Wen, +4 more
26citations -
CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab2022 Journal of Neurology Neurosurgery & Psychiatry article Medicine Migraine and Headache Studies Open access
Simone de Vries Lentsch, Linda Al‐Hassany, Michel Dominique Ferrari, Gisela Marie Terwindt, Antoinette MaassenVanDenBrink
20citations